Orchestra BioMed

OBIONasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$373.853 M

$6.22 -0.48%

Close of 22 Sept 2026

Revenue

$33.5M

#2852 by revenue

Earnings

-$52.7M

Loss-making

Shares outstanding

60,105,049

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#10Tilray BrandsTLRY$625.1M
#11Canopy GrowthCGC$409.2M
#12Orchestra BioMedOBIO$373.9M
#13SndlSNDL$347.0M
#14Usana Health SciencesUSNA$273.1M

What if Orchestra BioMed were worth as much as…

Open the what-if tool →

Gold $30.2T

$503,018.80

Per share 80,871× higher

Bitcoin $1.74T

$28,976.85

Per share 4,659× higher

Nvidia $5.52T

$91,768.78

Per share 14,754× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Orchestra BioMed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.